Sampling substrates by skin permeabilization

Dermatokinetics of Therapeutic Agents

Volumn , Issue , 2011, Pages 149-174

  Delgado Charro, M Begoña ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885957526     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (120)

1. Peck, C. C., K. Lee, and C. E. Becker. 1981. Continuous transepidermal drug collection: Basis for use in assessing drug intake and pharmacokinetics. J Pharmacokinet Biopharm 9:41-58
2. Peck, C. C., B. J. Bolden, R. G. Alimirez et al. 1987. Outward transdermal migration of theophylline. Pharmacol Skin 1:201-208
3. Peck, C. C., D. P. Conner, B. J. Bolden et al. 1988. Outward transcutaneous chemical migration: Implications for diagnostics and dosimetry. Skin Pharmacol 1:14-23
4. Conner, D. P., R. G. Almirez, P. Rhyne, K. Zamani, B. J. Bolden, and C. C. Peck. 1989. Transcutaneous collection of theophylline: Constancy and linearity of skin permeability. Skin Pharmacol 2:155-161
5. Bradley, C. R., R. G. Almirez, D. P. Conner, P. R. Rhyne, and C. C. Peck. 1990. Noninvasive transdermal chemical collection. II. In vitro and in vivo skin permeability studies. Skin Pharmacol 3:227-235
6. Murphy, M. G., C. C. Peck, D. P. Conner, K. Zamani, G. B. Merenstein, and D. Rodden. Transcutaneous theophylline collection in preterm infants. Clin Pharmacol Ther 47:427-434
7. Conner, D. P., E. Millora, K. Zamani et al. 1991. Transcutaneous chemical collection of caffeine in normal subjects: Relationship to area under the plasma concentration-time curve and sweat production. J Invest Dermatol 96:186-190
8. Pellett, M. A., J. Hadgraft, and M. S. Roberts. 1999. The back diffusion of glucose across human skin in vitro. Int J Pharm 193:27-35
9. Kintz, P., A. Tracqui, and P. Mangin. 1996. Sweat testing for benzodiazepines. J Forensic Sci 41:851-854
10. Cone, E. J., M. J. Hillsgrove, A. J. Jenkins, R. M. Keenan, and W. D. Darwin. 1994. Sweat testing for heroin, cocaine, and metabolites. J Anal Toxicol 18:298-305
11. Kintz, P., R. Brenneisen, P. Bundeli, and P. Mangin. 1997. Sweat testing for heroin and metabolites in a heroin maintenance program. Clin Chem 43:736-739
12. Kidwell, D. A., J. D. Kidwell, F. Shinohara et al. 2003. Comparison of daily urine, sweat, and skin swabs among cocaine users. Forensic Sci Int 133:63-78
13. Kintz, P., A. Tracqui, C. Jamey, and P. Mangin. 1996. Detection of codeine and phenobarbital in sweat collected with a sweat patch. J Anal Toxicol 20:197-201
14. Kintz, P., A. Tracqui, P. Mangin, and Y. Edel. 1996. Sweat testing in opioid users with a sweat patch. J Anal Toxicol 20:393-397
15. Burns, M. and R. C. Baselt. 1995. Monitoring drug use with a sweat patch: An experiment with cocaine. J Anal Toxicol 19:41-48
16. Kalia, Y. N., A. Naik, J. Garrison, and R. H. Guy. 2004. Iontophoretic drug delivery. Adv Drug Deliv Rev 56:619-658
17. Delgado-Charro, M. B. and R. H. Guy. 2001. Transdermal iontophoresis for controlled drug delivery and non-invasive monitoring. Stp Pharma Sci 11:403-414
18. Delgado-Charro, M. B. 2009. Recent advances on transdermal iontophoretic drug delivery and non-invasive sampling. J Drug Deliv Sci Tech 19:75-88
19. Sage, B. H. and J. E. Riviere. 1992. Model systems in iontophoresis-Transport efficacy. Adv. Drug Deliv Rev 9:265-287
20. Sieg, A. and V. Wascotte. 2009. Diagnostic and therapeutic applications of iontophoresis. J Drug Target. Doi: 10.101080/10611860903089750
21. Leboulanger, B., R. H. Guy, and M. B. Delgado-Charro. 2004. Reverse iontophoresis for non-invasive transdermal monitoring. Physiol Meas 25:R35-R50
22. Ledger, P. W. 1992. Skin biological issues in electrically enhanced transdermal delivery. Adv. Drug Deliv Rev 9:289-307
23. Mudry, B., P. A. Carrupt, R. H. Guy, and M. B. Delgado-Charro. 2007. Quantitative structure-permeation relationship for iontophoretic transport across the skin. J Control Release 122:165-172
24. Mudry, B., R. H. Guy, and M. Begoña Delgado-Charro. 2006. Prediction of iontophoretic transport across the skin. J Control Release 111:362-367
25. Mudry, B., R. H. Guy, and M. B. Delgado-Charro. 2006. Transport numbers in transdermal iontophoresis. Biophys J 90:2822-2830
26. Mudry, B., R. H. Guy, and M. B. Delgado-Charro. 2006. Electromigration of ions across the skin: Determination and prediction of transport numbers. J Pharm Sci 95:561-569
27. Phipps, J. B., R. V. Padmanabhan, and G. A. Lattin. 1989. Iontophoretic delivery of model inorganic and drug ions. J Pharm Sci 78:365-369
28. Leboulanger, B., J. M. Aubry, G. Bondolfi, R. H. Guy, and M. B. Delgado-Charro. 2004. Lithium monitoring by reverse iontophoresis in vivo. Clin Chem 50:2091-2100
29. Sieg, A., R. H. Guy, and M. B. Delgado-Charro. 2004. Noninvasive glucose monitoring by reverse iontophoresis in vivo: Application of the internal standard concept. Clin Chem 50:1383-1390
30. Nixon, S., A. Sieg, M. B. Delgado-Charro, and R. H. Guy. 2007. Reverse iontophoresis of L-lactate: In vitro and in vivo studies. J Pharm Sci 96:3457-3465
31. Leboulanger, B., R. H. Guy, and M. B. Delgado-Charro. 2004. Non-invasive monitoring of phenytoin by reverse iontophoresis. Eur J Pharm Sci 22:427-433
32. Santi, P. and R. H. Guy. 1996. Reverse iontophoresis-Parameters determining electroosmotic flow: I. pH and ionic strength. J Control Release 38:159-165
33. Santi, P. and R. H. Guy. 1996. Reverse iontophoresis-Parameters determining electroosmotic flow. II: Electrode chamber formulation. J Control Release 42:29-36
34. Merino, V., A. Lopez, D. Hochstrasser, and R. H. Guy. 1999. Noninvasive sampling of phenylalanine by reverse iontophoresis. J Control Release 61:65-69
35. Glikfeld, P., R. S. Hinz, and R. H. Guy. 1989. Noninvasive sampling of biological fluids by iontophoresis. Pharm Res 6:988-990
36. Rao, G., P. Glikfeld, and R. H. Guy. 1993. Reverse iontophoresis: Development of a noninvasive approach for glucose monitoring. Pharm Res 10:1751-1755
37. Rao, G., R. H. Guy, P. Glikfeld et al. 1995. Reverse iontophoresis: Noninvasive glucose monitoring in vivo in humans. Pharm Res 12:1869-1873
38. Green, P. G., R. S. Hinz, A. Kim, F. C. Szoka, and R. H. Guy. 1991. Iontophoretic delivery of a series of tripeptides across the skin in vitro. Pharm Res 8:1121-1127
39. Tamada, J. A., N. J. Bohannon, and R. O. Potts. 1995. Measurement of glucose in diabetic subjects using noninvasive transdermal extraction. Nat Med 1:1198-1201
40. Potts, R. O., J. A. Tamada, and M. J. Tierney. 2002. Glucose monitoring by reverse iontophoresis. Diabetes Metab Res Rev 18 Suppl 1:S49-S53
41. Tierney, M. J., J. A. Tamada, R. O. Potts, L. Jovanovic, and S. Garg. 2001. Clinical evaluation of the GlucoWatch biographer: A continual, non-invasive glucose monitor for patients with diabetes. Biosens Bioelectron 16:621-629
42. Tierney, M. J., J. A. Tamada, R. O. Potts et al. 2000. The GlucoWatch biographer: A frequent automatic and noninvasive glucose monitor. Ann Med 32:632-641
43. Pitzer, K. R., S. Desai, T. Dunn, S. et al. 2001. Detection of hypoglycemia with the GlucoWatch biographer. Diabetes Care 24:881-885
44. Garg, S. K., R. O. Potts, N. R. Ackerman, S. J. Fermi, J. A. Tamada, and H. P. Chase. 1999. Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. Diabetes Care 22:1708-1714
45. Tamada, J. A., N. J. Bohannon, and R. O. Potts. 1995. Measurement of glucose in diabetic subjects using noninvasive transdermal extraction. Nat Med 1:1198-1201
46. Sieg, A., R. H. Guy, and M. B. Delgado-Charro. 2004. Simultaneous extraction of urea and glucose by reverse iontophoresis in vivo. Pharm Res 21:1805-1810
47. Hagstrom-Toft, E., S. Enoksson, E. Moberg, J. Bolinder, and P. Arner. 1997. Absolute concentrations of glycerol and lactate in human skeletal muscle, adipose tissue, and blood. Am J Physiol 273:E584-E592
48. Hagstrom, E., P. Arner, U. Ungerstedt, and J. Bolinder. 1990. Subcutaneous adipose tissue: A source of lactate production after glucose ingestion in humans. Am J Physiol 258:E888-E893
49. Wascotte, V., M. B. Delgado-Charro, E. Rozet et al. 2007. Monitoring of urea and potassium by reverse iontophoresis in vitro. Pharm Res 24:1131-1137
50. Wascotte, V., M. B. Delgado-Charro, R. H. Guy, and V. Preat. 2004. Monitoring renal function by reverse iontophoresis. Eur J Pharm Sci 23:S57-S57
51. Wascotte, V., P. Caspers, J. de Sterke, M. Jadoul, R. H. Guy, and V. Preat. 2007. Assessment of the "Skin reservoir" of urea by confocal raman microspectroscopy and reverse iontophoresis in vivo. Pharm Res 24:1897-1901
52. Sieg, A., F. Jeanneret, M. Fathi, D. Hochstrasser, S. Rudaz, J. L. Veuthey, R. H. Guy, and M. B. Delgado-Charro. 2009. Extraction of amino acids by reverse iontophoresis in vivo. Eur J Pharm Biopharm. 72, 226-231
53. Sieg, A., F. Jeanneret, M. Fathi, D. Hochstrasser, S. Rudaz, J. L. Veuthey, R. H. Guy, and M. B. Delgado-Charro. 2008. Extraction of amino acids by reverse iontophoresis: Simulation of therapeutic monitoring in vitro. Eur J Pharm Biopharm 70:908-913
54. Bouissou, C. C., J. P. Sylvestre, R. H. Guy, M. B. Delgado-Charro. 2009. Reverse iontophoresis of amino acids: Identification and separation of stratum corneum and subdermal sources in vitro. Pharm Res. 26(12), 2630-2638
55. The Diabetes Control and Complications Trial Research Group. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
56. Potts, R. O., J. A. Tamada, and M. J. Tierney. 2002. Glucose monitoring by reverse iontophoresis. Diabetes Metab Res Rev 18:S49-S53
57. Tamada, J. A., S. Garg, L. Jovanovic, K. R. Pitzer, S. Fermi, and R. O. Potts. 1999. Noninvasive glucose monitoring: Comprehensive clinical results. Cygnus Research Team. JAMA 282:1839-1844
58. Eastman, R. C., H. P. Chase, B. Buckingham et al. 2002. Use of the GlucoWatch biographer in children and adolescents with diabetes. Pediatr Diabetes 3:127-134
59. Eastman, R. C., A. D. Leptien, and H. P. Chase. 2003. Cost-effectiveness of use of the GlucoWatch Biographer in children and adolescents with type 1 diabetes: A preliminary analysis based on a randomized controlled trial. Pediatr Diabetes 4:82-86
60. Tura, A., A. Maran, and G. Pacini. 2007. Non-invasive glucose monitoring: Assessment of technologies and devices according to quantitative criteria. Diabetes Res Clin Pract 77:16-40
61. Tierney, M. J., Y. Jayalakshmi, N. A. Parris, M. P. Reidy, C. Uhegbu, and P. Vijayakumar. 1999 Design of a biosensor for continual, transdermal glucose monitoring. Clin Chem 45:1681-1683
62. The diabetes research in children network (DirecNet) study group. 2004. Accuracy of the GlucoWatch G2 Biographer and the continuous glucose monitoring system during hypoglycemia: Experience of the Diabetes Research in Children Network. Diabetes Care 27:722-726
63. Nunnold, T., S. R. Colberg, M. T. Herriott, and C. T. Somma. 2004. Use of the noninvasive GlucoWatch Biographer during exercise of varying intensity. Diabetes Technol Ther 6:454-462
64. Tamada, J. A., T. L. Davis, A. D. Leptien et al. 2004. The effect of preapplication of corticosteroids on skin irritation and performance of the GlucoWatch G2 Biographer. Diabetes Technol Ther 6:357-367
65. Mendosa, D., 2006, The Glucowatch Biographer-Update, http://www.diabetesnet. com/diabetes_technology/glucowatch.php
66. Mize, N. K., M. Buttery, P. Daddona, C. Morales, and M. Cormier. 1997. Reverse iontophoresis: Monitoring prostaglandin E2 associated with cutaneous inflammation in vivo. Exp Dermatol 6:298-302
67. Gruemer, H. D., G. F. Grannis, L. B. Hetland, and M. L. Costantini. 1971. Amino acid transport and mental retardation. Clin Chem 17:1129-1131
68. Longo, N., S. K. Li, G. Yan et al. 2007. Noninvasive measurement of phenylalanine by iontophoretic extraction in patients with phenylketonuria. J Inherit Metab Dis 30:910-915
69. Sylvestre, J. P. 2007. Applications of iontophoresis in sports medicine. PhD Thesis. University of Bath
70. Degim, I. T., S. Ilbasmis, R. Dundaroz, and Y. Oguz. 2003. Reverse iontophoresis: A noninvasive technique for measuring blood urea level. Pediatr Nephrol 18:1032-1037
71. Wascotte, V., E. Rozet, A. Salvaterra et al. 2008. Non-invasive diagnosis and monitoring of chronic kidney disease by reverse iontophoresis of urea in vivo. Eur J Pharm Biopharm 69:1077-1082
72. Djabri, A., R. H. Guy, and M. B. Delgado-Charro. 2009. Transdermal reverse iontophoresis of iohexol as a tool for minimally-invasive monitoring of renal function. 10th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology, Nice, France, 9-14th September 2007
73. Djabri, A., W. Van't Hoff, P. Brock, I. C. K. Wong, R. H. Guy, and M. B. Delgado-Charro. Non-invasive assessment of renal function via transdermal reverse iontophoresis of iohexol: A pilot study. 11th International Congress of TDM & Clinical Toxicology, Montreal, Canada, 3-8th October 2009
74. Djabri, A. 2009. Iontophoresis in paediatric medicine: Non-invasive drug delivery and monitoring applications. PhD Thesis. University of Bath
75. Billat, V. L., P. Sirvent, G. Py, J. P. Koralsztein, and J. Mercier. 2003. The concept of maximal lactate steady state: A bridge between biochemistry, physiology and sport science. Sports Med 33:407-426
76. Kellum, J. A. 1998. Lactate and pHi: Our continued search for markers of tissue distress. Crit Care Med 26:1783-1784
77. Delgado-Charro, M. B. and R. H. Guy. 2003. Transdermal reverse iontophoresis of valproate: A noninvasive method for therapeutic drug monitoring. Pharm Res 20:1508-1513
78. Wascotte, V., B. Leboulanger, R. H. Guy, and M. B. Delgado-Charro. 2005. Reverse iontophoresis of lithium: Electrode formulation using a thermoreversible polymer. Eur J Pharm Biopharm 59:237-240
79. Leboulanger, B., M. Fathi, R. H. Guy, and M. B. Delgado-Charro. 2004. Reverse iontophoresis as a noninvasive tool for lithium monitoring and pharmacokinetic profiling. Pharm Res 21:1214-1222
80. Nicoli, S. and P. Santi. 2006. Transdermal delivery of aminoglycosides: Amikacin transport and iontophoretic non-invasive monitoring. J Control Release 111:89-94
81. Sekkat, N., A. Naik, Y. N. Kalia, P. Glikfeld, and R. H. Guy. 2002. Reverse iontophoretic monitoring in premature neonates: Feasibility and potential. J Control Release 81:83-89
82. M. J. Tierney, H. L. Kim, M. D. Burns, J. A. Tamada, R. O. Potts. 2000. Electroanalysis of glucose in transcutaneously extracted samples. Electroanalysis 12 666-671
83. Sieg, A., R. H. Guy, and M. B. Delgado-Charro. 2003. Reverse iontophoresis for noninvasive glucose monitoring: the internal standard concept. J Pharm Sci 92:2295-2302
84. Escobar-Chavez, J. J. D., D. Bonilla-Marti Nez, M. A. Villegas-Gonzalez, and A. L. Revilla-Vazquez. 2009. Electroporation as an efficient physical enhancer for skin drug delivery. J Clin Pharmacol. Doi:10.1177/0091270009344984
85. Murthy, S. N., Y. L. Zhao, S. W. Hui, and A. Sen. 2005. Electroporation and transcutaneous extraction (ETE) for pharmacokinetic studies of drugs. J Control Release 105:132-141
86. Murthy, S. N. and S. Zhang. 2008. Electroporation and transcutaneous sampling (ETS) of acyclovir. J Dermatol Sci 49:249-251
87. Sammeta, S. M., S. R. Vaka, and S. N. Murthy. 2009. Transcutaneous sampling of ciprofloxacin and 8-methoxypsoralen by electroporation (ETS technique). Int J Pharm 369:24-29
88. Sammeta, S. M., S. R. Vaka, and S. N. Murthy. 2009. Dermal drug levels of antibiotic (cephalexin) determined by electroporation and transcutaneous sampling (ETS) technique. J Pharm Sci 98:2677-2685
89. Srinivasa Murthy, S., V. Siva Ram Kiran, S. Mathur, and S. Narasimha Murthy. 2008. Noninvasive transcutaneous sampling of glucose by electroporation. J Diabetes Sci Technol 2:250-254
90. Wong, T. W., C. H. Chen, C. C. Huang, C. D. Lin, and S. W. Hui. 2006. Painless electroporation with a new needle-free microelectrode array to enhance transdermal drug delivery. J Control Release 110:557-565
91. Mitragotri, S. and J. Kost. 2004. Low-frequency sonophoresis: A review. Adv Drug Deliv Rev 56:589-601
92. Merino, G., Y. N. Kalia, and R. H. Guy. 2003. Ultrasound-enhanced transdermal transport. J Pharm Sci 92:1125-1137
93. Merino, G., Y. N. Kalia, M. B. Delgado-Charro, R. O. Potts, and R. H. Guy. 2003. Frequency and thermal effects on the enhancement of transdermal transport by sonophoresis. J Control Release 88:85-94
94. Alvarez-Roman, R., G. Merino, Y. N. Kalia, A. Naik, and R. H. Guy. 2003. Skin permeability enhancement by low frequency sonophoresis: Lipid extraction and transport pathways. J Pharm Sci 92:1138-1146
95. Kost, J., S. Mitragotri, R. A. Gabbay, M. Pishko, and R. Langer. 2000. Transdermal monitoring of glucose and other analytes using ultrasound. Nat Med 6:347-350
96. Cantrell, J. T., M. J. McArthur, and M. V. Pishko. 2000. Transdermal extraction of interstitial fluid by low-frequency ultrasound quantified with 3H2O as a tracer molecule. J Pharm Sci 89:1170-1179
97. Mitragotri, S., M. Coleman, J. Kost, and R. Langer. 2000. Transdermal extraction of analytes using low-frequency ultrasound. Pharm Res 17:466-470
98. Mitragotri, S., M. Coleman, J. Kost, and R. Langer. 2000. Analysis of ultrasonically extracted interstitial fluid as a predictor of blood glucose levels. J Appl Physiol 89:961-966
99. Cook, C. J. 2002. Rapid noninvasive measurement of hormones in transdermal exudate and saliva. Physiol Behav 75:169-181
100. Chuang, H., E. Taylor, and T. W. Davison. 2004. Clinical evaluation of a continuous minimally invasive glucose flux sensor placed over ultrasonically permeated skin. Diabetes Technol Ther 6:21-30
101. Lee, S., V. Nayak, J. Dodds, M. Pishko, and N. B. Smith. 2005. Glucose measurements with sensors and ultrasound. Ultrasound Med Biol 31:971-977
102. Echo therapeutics. 2008. Echo therapeutics announces positive results of a clinical study. http://www.echotx.com/files/attachments/echotx/Newsroom/Echo_Abstract_ Presentation_MR1_Study_Final%20(2).pdf
103. Gupta, J. and M. R. Prausnitz. 2009. Recovery of skin barrier properties after sonication in human subjects. Ultrasound Med Biol 35:1405-1408
104. Prausnitz, M. R. 2004. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 56:581-587
105. McAllister, D. V., P. M. Wang, S. P. Davis et al. 2003. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies. Proc Natl Acad Sci USA 100:13755-13760
106. Sivamani, R. K., D. Liepmann, and H. I. Maibach. 2007. Microneedles and transdermal applications. Expert Opin Drug Deliv 4:19-25
107. Kaushik, S., A. H. Hord, D. D. Denson et al. 2001. Lack of pain associated with microfabricated microneedles. Anesth Analg 92:502-504
108. Zahn, J. D., Y. C. Hsieh, and M. Yang. 2005. Components of an integrated microfluidic device for continuous glucose monitoring with responsive insulin delivery. Diabetes Technol Ther 7:536-545
109. Friedl, K. E. 2005. Analysis: Optimizing microneedles for epidermal access. Diabetes Technol Ther 7:546-548
110. Bal, S. M., J. Caussin, S. Pavel, and J. A. Bouwstra. 2008. In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci 35:193-202
111. Haq, M. I., E. Smith, D. N. John et al. 2009. Clinical administration of microneedles: Skin puncture, pain and sensation. Biomed Microdevices 11:35-47
112. Verbaan, F. J., S. M. Bal, D. J. van den Berg et al. 2008. Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method. J Control Release 128:80-88
113. Mukerjee, E. V., S. D. Collins, R. R. Isseroff, and R. L. Smith. 2004. Microneedle array for transdermal biological fluid extraction and in situ analysis. Sens Actuators A Phys 114:267-275
114. Wang, P. M., M. Cornwell, and M. R. Prausnitz. 2005. Minimally invasive extraction of dermal interstitial fluid for glucose monitoring using microneedles. Diabetes Technol Ther 7:131-141
115. Vesper, H. W., P. M. Wang, E. Archibold, M. R. Prausnitz, and G. L. Myers. 2006. Assessment of trueness of a glucose monitor using interstitial fluid and whole blood as specimen matrix. Diabetes Technol Ther 8:76-80
116. Smith, A., D. Yang, H. Delcher, J. Eppstein, D. Williams, and S. Wilkes. 1999. Fluorescein kinetics in interstitial fluid harvested from diabetic skin during fluorescein angiography: Implications for glucose monitoring. Diabetes Technol Ther 1:21-27
117. Burdick, J., P. Chase, M. Faupel, B. Schultz, and S. Gebhart. 2005. Real-time glucose sensing using transdermal fluid under continuous vacuum pressure in children with type 1 diabetes. Diabetes Technol Ther 7:448-455
118. Nindl, B. C., A. P. Tuckow, J. A. Alemany et al. 2006. Minimally invasive sampling of transdermal body fluid for the purpose of measuring insulin-like growth factor-I during exercise training. Diabetes Technol and Ther 8:244-252
119. Paranjape, M., J. Garra, S. Brida, T. Schneider, R. White, and J. Currie. 2003. A PDMS dermal patch for non-intrusive transdermal glucose sensing. Sens Actuators A Phys 104:195-204
120. Herndon, T. O., S. Gonzalez, T. R. Gowrishankar, R. R. Anderson, and J. C. Weaver. 2004. Transdermal microconduits by microscission for drug delivery and sample acquisition. BMC Med 2:12. http://www.biomedcentral.com/1741-7015.2